Respiratory gating based on external surrogates is performed in many clinics. We have developed a new technique for treatment verification using an electronic portal imaging device (EPID) in cine mode for gated 3D conformal therapy. Implanted radiopaque fiducial markers inside or near the target are required for this technique. The markers are contoured on the planning CT set, enabling us to create digitally reconstructed radiographs (DRRs) for each treatment beam. During the treatment, a sequence of EPID images can be acquired without disrupting the treatment. Implanted markers are visualized in the images and their positions in the beam's eye view are calculated offline and compared to the reference position by matching the field apertures in corresponding EPID and DRR images. The precision of the patient setup, the placement of the beam-gating window, as well as the residual tumour motion can be assessed for each treatment fraction. This technique has been demonstrated with a case study patient, who had three markers implanted in his liver. For this patient, the intra-fractional variation of all marker positions in the gating window had a 95% range of 4.8 mm in the SI direction (the primary axis of motion). This was about the same (5 mm) as the residual motion considered in the planning process. The inter-fractional variation of the daily mean positions of the markers, which indicates the uncertainty in the set-up procedure, was within +8.3 mm/−4.5 mm (95% range) in the SI direction for this case.
Introduction
Tumours in the abdomen and thorax often move due to respiration (Langen and Jones 2001 , Weiss et al 1972 , Suramo et al 1984 , Davies et al 1994 , Balter et al 1996 , Shimizu et al 1999 , Bryan et al 1984 , Ross et al 1990 , Ekberg et al 1998 . The expansion of margins to accommodate for motion leads to greater irradiation of normal tissues than for static tumours. To mitigate the effect of motion, many treatment methods have been proposed or are in current clinical usage (Ohara et al 1989 , Minohara et al 2000 , Kubo and Hill 1996 , Keall et al 2001 , Mageras et al 2001 , Maruhashi et al 1992 , Mageras and Yorke 2004 , Vedam et al 2001 , Zhang et al 2003 , Shirato et al 2000 , Wong et al 1999 , Berbeco et al 2004a , Schweikard et al 2000 . In respiratory gating, surrogates of tumour location are used to trigger the therapeutic beam. Shirato et al have established a method for gating based on the three-dimensional location of a fiducial implanted near the tumour. Continuous multi-view fluoroscopy assures the user that the radiation is being delivered accurately. Schweikard et al used infrared external markers and implanted radiopaque markers to periodically reestablish the internal/external correlation throughout a Cyberknife system (Accuray, Inc, Sunnyvale, CA USA) irradiation session (Schweikard et al 2000) . Berbeco et al have suggested the use of fluoroscopic images for gating based on organ motion induced intensity variations and template-matching, without the use of implanted surrogates (Berbeco et al 2004a) . Wong et al pioneered spirometry as a surrogate for tumour location (Wong et al 1999) . Many institutions have also worked to develop techniques for respiratory gating based on the position of an external surrogate (or a collection of them) placed on the thorax and/or abdomen (Kubo and Hill 1996 , Vedam et al 2001 , Kubo et al 2000 , Ozhasoglu and Murphy 2002 , Ramsey et al 1999 . The strategies that do not use internal anatomy monitoring during the treatment have a built-in assumption that the correlation between the surrogate and the tumour is known and does not change in an unpredictable way throughout the course of treatment. The correlation between these surrogates and internal anatomy is the source of much research and debate (Schweikard et al 2004 , Koch et al 2004 , Starkschall et al 2004 , Tsunashima et al 2004 , Vedam et al 2003 , Ahn et al 2004 , Hoisak et al 2004 . If the correlation is not repeatable, or is not predictable, then some method of online or offline monitoring of the treatment should be used to ensure the proper placement of the dose. The purpose of this study is not to prove or disprove the internal/external correlation, but to present an idea for a clinical tool that may be used for quality assurance of external signal based gated treatment. Ford et al developed a method for determining the residual motion by manually triggering the EPID during treatment and finding the location of the diaphragm (Ford et al 2002) . The technique described in this paper improves upon this idea. Our method has been developed for retrospective analysis, but in the future it may be applied in real time for online verification of gated treatment.
Methods and materials

Treatment planning
A case study is presented to illustrate the basic features of our method for gated treatment verification. The patient was a 72 year old male with a large liver tumour. Three gold cylindrical radiopaque 'seeds', 0.8 mm in diameter and 3 mm in length, were implanted at the left, right and inferior borders of the tumour, respectively. The seeds were implanted with their long axis roughly aligned with the patient's SI axis for maximum visibility from angles orthogonal to this axis. The tumour motion was assessed during a fluoroscopic simulation and was found to be mostly cranial-caudal with an amplitude of ∼2 cm peak to peak. The patient underwent a 4DCT scan under video breath coaching conditions (Rietzel et al 2004 , Pan et al 2004 . The resorted CT data sets also showed a 2 cm peak-to-peak motion of the markers. From the analysis of the 4DCT data set, the gating window was determined and the end-of-exhale CT set was chosen for treatment planning. A five-field coplanar 3D conformal 
Patient set-up
Breath coaching was continued throughout patient positioning and beam delivery each day. The patient position was set-up at end of exhale using simultaneous orthogonal diagnostic x-ray images captured with an onboard imaging system (Berbeco et al 2004b) . The diagnostic imaging system has not yet been integrated with the RPM system, so 'manual' gating was used.
The set-up images were taken while the therapist was watching the RPM trace on a control room monitor. He/she took the images while the RPM signal was within the amplitude-gating window. We estimate that the error associated in the hand-eye coordination involved in this could be as large as the entire width of the gate, i.e. 5 mm. The threshold of action for moving the patient was also 5 mm when the set-up images were compared to the set-up DRRs. Future improvements to our set-up procedure, including integration with the RPM system, automated shift calculation and a smaller threshold of action should improve the accuracy of our gated set-up procedure.
Gated treatment
Gated treatment was performed on a Varian 21EX linac (Varian Medical Systems, Palo Alto, CA, USA) equipped with an AS500 electronic portal imaging device (EPID) and the PortalVision software. A Varian real-time position management (RPM) system was used as an external surrogate-gating tool. During the treatment, the EPID was set to acquire images in the cine mode at a frame rate of approximately 1 image every 1.6 s. The integration time for each image was approximately 0.5 s. When in cine mode, EPID acquisition is not triggered by the linac. Rather, the EPID continuously, passively acquires images, even when the RPM signals the linac to hold off the therapy beam. No extra radiation is given to the patient. With this technique, many of the EPID images are taken during periods when the treatment beam is off. These 'blank' images are discarded while the good images are kept (there is some 'ghosting', but it is trivial to determine which images are ghosts). In general, there is at least one good image from each beam-on period (RPM marker box is in the gating window), depending on the duration of the particular gate. For a treatment duty cycle of 30%, roughly 1/3 of the acquired EPID images are analysable. The images were exported from PortalVision and analysed in a separate program.
Analysis
An interactive data language (Research Systems, Inc., Boulder, CO, USA) program has been written to analyse the EPID images. Each image is examined offline. The seed locations are digitized and compared to the corresponding seed contours in the DRRs. The field aperture edges are used to register each treatment image with the corresponding DRR and the seed positions are quantified with respect to them. The seed positions in the treatment images are the result of both inter-fractional and intra-fractional variation. Due to the aforementioned issues with our diagnostic imaging set-up procedure, only the treatment images are used for analysis. The inter-fractional component is the patient positioning error. To assess the inter-fractional variation, the daily average of each seed position is calculated. The difference between the daily average of each seed and the corresponding seed contour was averaged over all five fields for each day. This is the daily inter-fractional error. The treatment was coplanar so the superior-inferior coordinate is the only one used in this calculation. Whereas the interfractional analysis evaluates the accuracy of treatment, the intra-fractional analysis evaluates the precision of treatment. The intra-fractional component is the residual motion of the tumour within the gating window. This is calculated by finding the deviation of the seeds in each image from the daily average. Using the daily average as the reference point means that the set-up error (i.e. the inter-fractional error) is taken out of the intra-fractional calculation. Seed movement was seen prevalently in the SI direction during simulation; therefore we extracted intra-fractional information along this axis.
Results and discussion
For the case study, a total of 608 analysable images were acquired over 15 fractions. The distribution of images per day and per field is shown in table 1. An example of a good verification image is shown in figure 1(a) for field #2. The corresponding DRR, with the GTV, PTV and seed positions contoured, is shown in figure 1(b) . The seed positions over the entire treatment are shown in figure 2 for each field. Also plotted is the DRR seed position for comparison. As an example, a close-up of the distribution for field 4, seed #2 is shown in figure 3 (a). Note that this distribution is the combination of all images for the same field, from all days. There are both inter-fractional and intra-fractional components leading to the spread in figure 3(a) . These can be separated and investigated individually, as described in section 2.4. 
Inter-fractional variations
The position of the daily average of each seed's position relative to the DRR is calculated. The inter-fractional variation in the SI direction for the combination of all the fields is shown in figure 4 . The distribution has its mean at zero with a longer tail in the positive SI direction.
To quantify the width of the distribution in figure 4 , a 95% range was defined. This is the limit within which 95% of the data are located. For the sample patient, we found this to be +8.3/−4.5 mm in the SI direction. The inter-fractional variation is plotted in figure 5 as a function of fraction for each field individually and the average of all the fields. Our set-up images on day 6 showed the seeds to be just below the action threshold (5 mm), so no shift was made. On the same day, field 3 (gantry at 95
• ) was the only one in which a negative SI variation was found during treatment. This is due to the proximity of seeds 1 and 2 in the images at this angle (see figure 2) . The analyst mistook the most superior seed for the one slightly more inferior. Days 8 and 9 had the largest variation, leading to the longer positive (superior) tail in figure 4. On day 8, the patient showed swelling in the stomach leading to a small rotation of the markers. Since rotation is not possible on our treatment couch, we made the best possible translation shift to accommodate the marker positions. It is unclear what led to the large variation on day 9.
Intra-fractional variations
The distribution of SI motion for the combination of all of the fields is shown in figure 6 . Note that the intra-fractional error for this patient in the SI direction is basically symmetric. The values for the 95% intra-fractional SI displacements are given in table 2. For the sample patient, we found the 95% ranges to be between 4.5 and 5.5 mm for the five fields. The 95% range of the combination of all the fields is 4.8 mm. This is within 4% of the residual motion considered in the planning process (5 mm). This does not validate gating universally, but it does give us added confidence in our gating procedure.
Seed visibility
Not all seeds can be seen in every image. Some beam orientations produce better quality images due to the thickness of the patient in the beam's eye-view and the relative positions of the clips and their proximity to high-density material (such as bone). The data in the last column of table 1 show that seeds could be better visualized from the 125
• beam than from the 330
• beam, even though the two are almost anti-parallel. The difference in beam energy may have also had an effect. The location of a seed can also be off by ±1 mm because of its length. In the future, automated feature detection algorithms can be used to find the seeds, relieving any inter-user variability.
Discussion of future work
We have proposed a new technique for verification of respiratory-gated treatment, and demonstrated its feasibility in a case study. An EPID is used in the cine mode to acquire images of the patient during gated irradiation. The images can be compared to the planning DRRs for each field to calculate the position of the tumour during irradiation. The data may be analysed retrospectively to assure accurate gated treatment. It may be beneficial to develop faster analysis methods to enable assessment during the course of treatment (e.g. after each day's session) or even online during the treatment. Online, real-time verification would require very fast recognition algorithms and integration with the EPID software.
The technique presented here was shown to be useful for a case study in which tumour location could be deduced from implanted radiopaque markers. The implantation of markers may not always be feasible, however. There is evidence of a high risk of pneumothorax during percutaneous implantation of markers in the lung (Topal and Ediz 2003 , Geraghty et al 2003 , Arslan et al 2002 , Laurent et al 2000a , 2000b . Some clinics have chosen an endoscopic method (Shirato et al 2003 , Yamazaki 2004 , however it has not been widely accepted. In the absence of radiopaque markers, the position of the tumour may be more difficult to find. For some locations, the diaphragm may be in the field of view and could act as a surrogate (Mageras et al 2001 , Vedam et al 2003 , Ford et al 2002 , Dawson et al 2001 , Wagman et al 2003 , Kimura et al 2004 , Plathow et al 2004a , Kim et al 2001 , Onishi et al 2003 , Plathow et al 2004b . For other locations, on the periphery of the lung, there may be enough contrast between tumour and lung to find the tumour directly. Significant image enhancing techniques may be needed to distinguish the tumour from the healthy anatomy (Berbeco et al 2004a) . These and other techniques should be developed as alternatives to marker-based verification for the cases in which marker implantation is not feasible.
With the effective tumour motion reduced by gating, clinicians may wish to prescribe an IMRT treatment. Obviously, the technique outlined here would have to be modified for that case. It has not yet been studied whether radiopaque markers can be seen in gated IMRT fields. If not, in-room or gantry mounted diagnostic x-rays may be needed to verify the marker position during irradiation. Drawbacks would be the elimination of the beam's eye-view benefit of the EPID and the delivery of some extra dose to the patient.
Conclusions
We suggest the implementation of the technique outlined in this paper as part of gated treatment quality assurance. The quantities evaluated in this paper need not be the only information extracted from the data. Clinics may find it useful to develop analyses to examine other relevant parameters. We will continue to use gating and build a statistical case for an appropriate clinical gating margin. A systematic study of a large sample of patients should be conducted to assess whether a single value for a motion margin should be used for all patients. The inter-fractional evaluation shows us that our set-up procedure may need some additional study and further data may suggest a suitable margin for patient set-up error.
